MedPath

A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person

Not Applicable
Terminated
Conditions
Diabetes Mellitus
Interventions
Other: diabetes education via telemedicine
Other: diabetes education in-person
Registration Number
NCT00629434
Lead Sponsor
State University of New York - Upstate Medical University
Brief Summary

This study compares group diabetes education in-person versus via telemedicine

Detailed Description

Diabetes education is important in the treatment of the person with diabetes. A diabetes self-management education program not only educates the patient and his/her family to the basics of diabetes care but also integrates diabetes care into daily life while providing coping skills to adjust to this chronic illness. Unfortunately, comprehensive diabetes care is not available to all persons with diabetes. One obstacle to the provision of comprehensive diabetes care is the unavailability of a diabetes treatment center. many people with diabetes live too far or do not have the transportation to be able to attend education programs that met national standards. We have shown that telemedicine is an effective means to provide comprehensive 1:1 individualized diabetes education to persons with diabetes. We now propose to test the hypothesis that diabetes groups education classes can be provided effectively through telemedicine technology to individuals living in rural areas. Patients with diabetes will received diabetes education via teleconferencing from our Joslin Diabetes center. The participants will be assessed before and after diabetes education via telemedicine using measures of glycemia (A1c) and assessments of patient satisfaction, emotional well being, and behavioral change and compared to results from participants attending our diabetes education classes in-person.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
68
Inclusion Criteria
  • Type 1 or type 2 diabetes mellitus
  • age > 18 years
Exclusion Criteria
  • Profound vision loss
  • Severe hearing impairment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1diabetes education via telemedicineThis arm will receive diabetes education via telemedicine
2diabetes education in-persondiabetes education in-person
Primary Outcome Measures
NameTimeMethod
A1cbaseline, 3 mo post intervention, 6 mo post intervention
Secondary Outcome Measures
NameTimeMethod
PAID scalebaseline, 3 and 6 months post intervention
Diabetes Treatment Satisfaction QuestionnaireBaseline, 3 and 6 months post intervention

Trial Locations

Locations (1)

Joslin Diabetes Center Affiliate at SUNY Upstate Medical University

🇺🇸

Syracuse, New York, United States

© Copyright 2025. All Rights Reserved by MedPath